• VUB researchers discover how lactic acid weakens anti-tumour defences

    Monday January 31st 2022

  • Pre-existing immune cells can predict early response to hepatitis B vaccine

    Tuesday January 25th 2022

  • ElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer

    Tuesday January 25th 2022

  • Biotalys achieves breakthrough in protein expression increasing commercial potential for its first biofungicide Evoca

    Tuesday January 25th 2022

  • KU Leuven kiest met Open Data-aanpak resoluut voor Open Wetenschap

    Thursday January 20th 2022

  • Belgian research team uses AI to explain cell diversity in the fly brain

    Thursday January 6th 2022

  • VIB research at the basis of experimental gene therapy against dementia

    Wednesday December 22nd 2021

  • reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase

    Thursday October 21st 2021

  • Your news here?

  • Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging

    Tuesday October 12th 2021

  • Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development

    Tuesday October 12th 2021

  • KU Leuven develops very potent antiviral against dengue

    Thursday October 7th 2021


Strategic Partners